A Monoclonal Antibody to α1β1 Blocks Antigen-induced Airway Responses in Sheep

American Journal of Respiratory and Critical Care Medicine

Volumn 169, Issue 1, 2004, Pages 97-104

  Abraham, William M ^a   Ahmed, Ashfaq ^b   Serebriakov, Irakli ^b   Carmillo, Amie N ^b   Ferrant, Janine ^b   De Fougerolles, Antonin R ^b   Garber, Ellen A ^b   Gotwals, Philip J ^b   Koteliansky, Victor E ^b   Taylor, Fred ^b   Lobb, Roy R ^b  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b NONE

Author keywords

Animal model; Asthma; CD49a; Inflammation; Integrin

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN G1 ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY AQC2; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 1; INTEGRIN; VERY LATE ACTIVATION ANTIGEN;

AEROSOL; AIRWAY HYPERRESPONSIVENESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; WILD TYPE; AIRWAY RESISTANCE; ANIMAL; BRONCHUS HYPERREACTIVITY; COMPARATIVE STUDY; DISEASE MODEL; DRUG ANTAGONISM; FEMALE; IMMUNOLOGY; INHALATION TEST; INHALATIONAL DRUG ADMINISTRATION; MALE; PHYSIOLOGY; PROBABILITY; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SHEEP;

ADMINISTRATION, INHALATION; AIRWAY RESISTANCE; ANIMALS; ANTIBODIES, MONOCLONAL; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; DISEASE MODELS, ANIMAL; FEMALE; INTEGRINS; MALE; PROBABILITY; RECEPTORS, VERY LATE ANTIGEN; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SHEEP, DOMESTIC;

EID: 1242276093     PISSN: 00030805     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200304-543oc     Document Type: Article

References (39)

1. 4-integrins mediate antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep. J Clin Invest 1994;93:776-787.
2. Henderson WR, Chi EY, Albert RK, Chu SJ, Lamm WJ, Rochon Y, Jonas M, Christie PE, Harlan JM. Blockade of CD49d (alpha4 integrin) on intrapulmonary but not circulating leukocytes inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma. J Clin Invest 1997;100:3083-3092.
3. Jarjour NN, Calhoun WJ, Kelly EA, Gleich GJ, Schwartz LB, Busse WW. The immediate and late allergic response to segmental bronchopulmonary provocation in asthma. Am J Respir Crit Care Med 1997; 155:1515-1521.
4. de Monchy JGR, Kauffman HF, Venge P, Koeter GH, Jansen HM, Sluiter HJ, de Vries K. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1985;131:373-376.
5. Abraham WM, Gill A, Ahmed A, Sielczak MW, Lauredo IT, Botvinnikova Y, Lin KC, Pepinsky B, Leone DR, Lobb RR, et al. A small-molecule, tight binding inhibitor of the integrin alpha(4)beta(1) blocks antigen-induced airway responses and inflammation in experimental asthma in sheep. Am J Respir Crit Care Med 2000;162:603-611.
6. Abraham WM, Ahmed A, Sabater JR, Lauredo IT, Botvinnikova Y, Bjercke RJ, Hu X, Revelle BM, Kogan TP, Scott IL, et al. Selectin blockade prevents antigen-induced late bronchial responses and airway hyperresponsiveness in allergic sheep. Am J Respir Crit Care Med 1999;159:1205-1214.
7. Wegner CD, Gundel RH, Reilly P, Haynes N, Letts LG, Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 1990;247:456-459.
8. Gundel RH, Wegner CD, Torcellini CA, Clarke CC, Rothlein R, Smith CW, Letts LG. Endothelial-leukocyte adhesion molecule-1 mediates antigen-induced acute airway inflammation and late-phase bronchoconstriction in monkeys. J Clin Invest 1991;88:1407-1411.
9. Belkin VM, Belkin AM, Koteliansky VE. Human smooth muscle VLA-1 integrin: purification, substrate specificity, localization in aorta, and expression during development. J Cell Biol 1990;111:2159-2170.
10. Duband JL, Belkin AM, Syfrig J, Thiery JP, Koteliansky VE. Expression of alpha 1 integrin, a laminin-collagen receptor, during myogenesis and neurogenesis in the avian embryo. Development 1992;116:585-600.
11. Hemler ME. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Anna Rev Immunol 1990:8:365-400.
12. Rubio MA, Sotillos M, Jochems G, Alvarez V, Corbi AL. Monocyte activation: rapid induction of a1/b1 (VLA-1) integrin expression by lipopolysaccharide and interferon-g. Eur J Immunol 1995;25:2701-2705.
13. Bank I, Roth D, Book M, Guterman A, Shnirrer I, Block R, Ehrenfeld M, Langevitz P, Brenner H, Pras M. Expression and functions of very late antigen 1 in inflammatory joint diseases. J Clin Immunol 1991;11:29-38.
14. Takahashi H, Soderstrom K, Nilsson E, Kiessling R, Patarroyo M. Integrins and other adhesion molecules on lymphocytes from synovial fluid and peripheral blood rheumatoid arthritis patients. Eur J Immunol 1992;22:2879-2885.
15. Stemme S, Holm J, Hansson GK. T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. Arterioscler Thromb 1992;12:206-211.
16. de Fougerolles AR, Sprague AG, Nickerson-Nutter CL, Chi-Rosso G, Rennert PD, Gardner H, Gotwals PJ, Lobb RR, Koteliansky VE. Regulation of inflammation by collagen-binding integrins alpha1beta1 and alpha2beta1 in models of hypersensitivity and arthritis. J Clin Invest 2000;105:721-729.
17. Krieglstein CF, Cerwinka WH, Sprague AG, Laroux FS, Grisham MB, Koteliansky VE, Senninger N, Granger DN, de Fougerolles AR. Collagen-binding integrin α1β1 regulates intestinal inflammation in experimental colitis. J Clin Invest 2002;110:1773-1782.
18. Fiorucci S, Mencarelli A, Palazzeti B, Sprague AG, Distrutti A, Morelli A, Novobrantseva G, Chirino G, Kotelianksy VE, de Fougerolles AR. Importance of innate immunity and collagen-binding integrin α1β1 in TNBS-induced colitis. Immunity 2002;17:769-780.
19. Karpusas M, Ferrant J, Weinreb PH, Taylor FR, Garber EA. Crystal structure of the alpha1beta1 integrin I domain in complex with a antibody Fab fragment. J Mol Biol 2003;327:1031-1041.
20. Leatherbarrow RJ, Rademacher TW. Effector functions of a monoclonal aglycosylated mouse IgG2a: binding and activation of complement component Cl and interaction with human monocyte Fc receptor. Mol Immunol 1985;22:407-415.
21. Nose M, Wigzell H. Biological significance of carbohydrate chains on monoclonal antibodies. Proc Natl Acad Sci USA 1983;80:6632-6636.
22. Tao MH, Morrison SL. Studies of aglycosylated chimeric mouse-human IgG: role of carbohydrate in the structure and effector functions mediated by the human IgG constant region. J Immunol 1989;143:2595-2601.
23. 1-proteinase inhibitor and tissue kallikrein in controlling allergic ovine airway hyperresponsiveness. Am J Respir Crit Care Med 1996;154:36-42.
24. 1-proteinase inhibitor blocks antigen- and mediator-induced airway responses in sheep. J Appl Physiol 2002;93:1900-1906.
25. Gotwals P, Chi-Rosso G, Ryan ST, Sizing I, Zafari M, Benjamin C, Singh J, Venyaminov SY, Pepinsky RB, Koteliansky VE. Divalent cations stabilize the a1b1 integrin I domain. Biochemistry 1999;38:8280-8288.
26. Masopust D, Vezys V, Marzo A, Lefrancois L. Preferential localization of effector memory T cells in nonlymphoid tissue. Science 2001;291:2413-2417.
27. Reinhardt RL, Khoruts A, Merica R, Zell T, Jenkins MK. Visualizing the generation of memory CD4 cells in the whole body. Nature 2001;410:101-105.
28. Andreasen SO, Thomsen AR, Koteliansky VE, Novobrantseva TI, Sprague AG, de Fougerolles AR, Christensen JP. Expression and functional importance of collagen-binding integrins, α1β1 and α2β1. on virus-activated cells. J Immunol 2003;171:2804-2811.
29. de Fougerolles AR, Koteliansky VE. Regulation of monocyte gene expression by the extracellular matrix and its functional implications. Immunol Rev 2002;186:208-220.
30. Henderson WRJ, Tang LO, Chu SJ, Tsao SM, Chiang GK, Jones F, Jonas M, Pae C, Wang H, Chi EY. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am J Respir Crit Care Med 2002;165:108-116.
31. Abraham WM. Of mice and men. Am J Respir Cell Mol Biol 2003;28:1-4.
32. Holtzman MJ. Drug development for asthma. Am J Respir Cell Mol Biol 2003;29:163-171.
33. Leckie MJ, ten Brinke A, Khan J, Diamant Z, O'Connor BJ, Walls CM, Mathur AK, Cowley HC, Chung KP, Djukanovic R, et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyperresponsiveness, and the late asthmatic response. Lancet 2000;356:2144-2148.
34. Flood-Page PT, Menzies-Gow AN, Kay AB, Robinson DS. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med 2003;167:199-204.
35. Isaacs JD, Clark MR. Therapy with monoclonal antibodies: an in vivo model for the assessment of therapeutic potential. J Immunol 1992;148:3062-3071.
36. Lobb RR, Hemler ME. The pathophysiologic role of α4 integrins in vivo. J Clin Invest 1994;94:1722-1728.
37. Babu KS, Arshad SH, Holgate ST. Omalizumab, a novel anti-IgE therapy in allergic disorders. Expert Opin Biol Ther 2001;1:1049-1058.
38. Borish LC, Nelson HS, Corren J, Bensch G, Busse WW, Whitmore JB, Agosti JM, Asthma Study Group. Efficacy of soluble IL-4 receptor for the treatment of adults with asthma. J Allergy Clin Immunol 2001;107:963-970.
39. Weitz-Schmidt G, Welzenbach K, Brinkmann V, Kamata T, Kallen J, Bruns C, Cottens S, Takada Y, Hommel U. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med 2001;7:687-692.